These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6120670)

  • 1. Atenolol: a long-acting beta 1- adrenoceptor antagonist.
    McLeod AA; Shand DG
    Ann Intern Med; 1982 Feb; 96(2):244-5. PubMed ID: 6120670
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 3. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of celiprolol and atenolol in the treatment of hypertension.
    Rosenthal F; Silke B; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():76-7. PubMed ID: 2864070
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.
    Frishman WH
    N Engl J Med; 1982 Jun; 306(24):1456-62. PubMed ID: 7043268
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative activity of atenolol and metoprolol.
    Comerford MB; Besterman EM
    Br Med J; 1977 Jul; 2(6081):260. PubMed ID: 18256
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.
    Robb OJ; Webster J; Petrie JC; Harry JD; Young J
    Br J Clin Pharmacol; 1988 Apr; 25(4):433-8. PubMed ID: 2898256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Once-daily atenolol for hypertension.
    Besterman E
    Br Med J; 1976 Jun; 1(6022):1403. PubMed ID: 6107
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled study of atenolol in treatment of hypertension.
    Hansson L; Aberg H; Karlberg BE; Westerlund A
    Br Med J; 1975 May; 2(5967):367-70. PubMed ID: 236810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta adrenergic blocking agents to control hypertension in aviation personnel.
    Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP
    Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.
    Macdonald MJ; Cullen PM; Phillips CI
    Br J Ophthalmol; 1976 Nov; 60(11):789-91. PubMed ID: 12782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J; Frishman WH
    N Engl J Med; 1981 Aug; 305(9):500-6. PubMed ID: 6114433
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
    Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.